571 – 580 of 660
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
A Healthy Hemophilic Patient without Arthropathy: From Concept to Clinical Reality.
- Contribution to journal › Article
-
Mark
Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?
- Contribution to journal › Article
-
Mark
Limited protective effect of the CCR5 Delta 32/CCR5 Delta 32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus
- Contribution to journal › Article
-
Mark
Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population
- Contribution to journal › Article
-
Mark
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
- Contribution to journal › Article
- 2002
-
Mark
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
- Contribution to journal › Article
-
Mark
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen
- Contribution to journal › Article
-
Mark
Unresolved issues in prophylaxis
- Contribution to journal › Article
-
Mark
Clinical outcomes and resource utilization associated with haemophilia care in Europe
- Contribution to journal › Article
-
Mark
Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans.
- Contribution to journal › Article